Recurrent and founder mutations in the Netherlands: Extensive clinical variability in Marfan syndrome patients with a single novel recurrent fibrillin-1 missense mutation*
Jan J.J. Aalberts(University Medical Center Groningen), J. Peter van Tintelen(Utrecht University), Yvonne Hilhorst‐Hofstee(Leiden University Medical Center), Maarten P. van den Berg(Regions Hospital), Barbara J.M. Mulder(Amsterdam UMC Location University of Amsterdam), Daniela Q.C.M. Barge‐Schaapveld(Leiden University), G. Bosman(University of Florida), Agnes G. Schuurman(University Medical Center Groningen), B Hamel(Radboud University Nijmegen), Gerard Pals(University Medical Center Groningen)
Cited by 4
Related Papers
2023 ESC Guidelines for the management of cardiomyopathies
|European Heart Journal|2023|2.3k
ESC Guidelines for the management of grown-up congenital heart disease (new version 2010): The Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC)
|European Heart Journal|2010|2.3k
The changing epidemiology of congenital heart disease
|Nature Reviews Cardiology|2010|757
Preoperative Thresholds for Pulmonary Valve Replacement in Patients With Corrected Tetralogy of Fallot Using Cardiovascular Magnetic Resonance
|Circulation|2007|613
Risk Factors for Malignant Ventricular Arrhythmias in Lamin A/C Mutation Carriers
|Journal of the American College of Cardiology|2012|519